Rubel & Ménasché has been acquired by Perwyn Advisors UK Ltd.
The shareholders of Rubel & Menasché have closed a third LBO, selling the company to Perwyn Advisors UK Ltd.
Rubel & Ménasché is an international French jewelry company specializing in small stones, based in the heart of Paris. Since its creation, the firm has distinguished itself by its quality of service and expertise. The company has been recognized by the most prestigious high-end jewelry and watchmaking houses, such as Cartier, Van Cleef & Arpels and Hermes. These blue-chip clients value its craftsmanship, reputation and reliability, having collaborated with the company for many years.
Perwyn Advisors UK Ltd. is a European private equity investor specializing in buy-out and growth capital investments in four sectors: technology, services, healthcare, and food and ingredients. The firm typically invests in a specific portfolio of companies with an enterprise value of between £50–500 million (US$63.5–635 million) and significant expansion potential.
Founded in 2014, Axio Capital is a France-based private equity firm headquartered in Paris. It manages the Axio Croissance investment company, the first evergreen SLP created in France, with a variable capital of US$61 million. This innovative investment vehicle, finalized in the first half of 2016, is subscribed by entrepreneurs and family offices. Axio Capital specializes in MBOs, spin-offs, OBOs and buy-and-build transactions.
Oaklins’ team in France acted as the exclusive financial advisor to the shareholders of Rubel & Ménasché in this transaction.
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn more